Neutralizing antibody response against human cytomegalovirus in allogeneic bone marrow-transplant recipients.
暂无分享，去创建一个
[1] M. Mach,et al. Strain-Specific Neutralization of Human Cytomegalovirus Isolates by Human Sera , 1999, Journal of Virology.
[2] H. Einsele,et al. Kinetics of the antibody response against human cytomegalovirus-specific proteins in allogeneic bone marrow transplant recipients. , 1998, The Journal of infectious diseases.
[3] G. Gentile,et al. Evaluation of a score system for the severity and outcome of cytomegalovirus interstitial pneumonia in allogeneic bone marrow recipients. , 1997, The Journal of infection.
[4] W. Leisenring,et al. Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. , 1997, Blood.
[5] T. Merigan,et al. Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. , 1997, The Journal of infectious diseases.
[6] V. Vullo,et al. Detection of cytomegalovirus‐matrix protein (pp65) in leukocytes of HIV‐infected patients with painful peripheral neuropathy , 1994, Journal of medical virology.
[7] S. Chou,et al. Neutralizing antibody responses to reinfecting strains of cytomegalovirus in transplant recipients. , 1989, The Journal of infectious diseases.
[8] W. Britt,et al. A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. , 1989, Journal of virological methods.